Earth Science Tech Inc. ETST Archives - Page 17 of 17

ThursdayMay 03, 2018 11:24 am

Earth Science Tech, Inc. (ETST) Poised to Benefit from Fast Growing Hemp-Derived CBD Market

12 more U.S. states likely to approve medicinal or recreational use of cannabis in 2018 Hemp-derived CBD market on course for CAGR of 55 percent over next five years Ventures in both MMJ and recreational marijuana hedge bets The tide of cannabis legalization sweeping over North America continues to rise despite intractable federal prohibition in the United States. In the U.S., 29 states and the District of Columbia allow cannabis for medical use. In nine of those jurisdictions, adult recreational use is also permitted. Another 12 are considering easing restrictions on cannabis use by the end of the year. In…

TuesdayMay 01, 2018 3:10 pm

QualityStocksNewsBreaks – Earth Science Tech, Inc. (ETST) Aims to Complete White Paper Studies in Early 2019

Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, anticipates completion of white paper studies in early 2019, with clinical trials to follow. An article discussing the company reads: “Earth Science Tech, Inc. (OTC: ETST) has set 2019 as the crucial year when the company anticipates completion of white paper studies and the start of human clinical trials to investigate the synergies of drugs that are intended to treat opioid dependency. It intends to test the effectiveness of combination drugs that contain a mineral element and full spectrum cannabinoid industrial hemp…

FridayApr 27, 2018 1:11 pm

Earth Science Tech, Inc. (ETST) Plans to Battle Opioid Addiction with Human Clinical Trials in 2019

Centers for Disease Control and Prevention, in March 2018, estimated ‘economic burden’ of opioid misuse at $78.5 billion annually ETST plans to complete white paper, begin human clinical trials by 2019; company intends to investigate drugs that combine mineral element and cannabinoid industrial hemp oil Goal for biotech company is to fight opioid addiction with over-the-counter (OTC) treatment drug and a cannabinoid companion generic drug Earth Science Tech, Inc. (OTC: ETST) is planning to fight opioid addiction in the near future by completing its white paper and beginning human clinical trials in 2019. The epidemic is projected to claim nearly…

MondayApr 23, 2018 12:10 pm

QualityStocksNewsBreaks – Earth Science Tech, Inc. (ETST) Employs Proactive Approach to Accelerate Development Growth

Innovative biotech company Earth Science Tech (OTC: ETST), through its partnership with Laboratories BNK Canada, Inc., is advancing toward commercialization of its new testing services. An article discussing the company reads: “Through ETST’s connection with Défi Montréal, key individuals have already been brought on board to advance the acceleration of operations. In January 2018, ETST announced a deal with Laboratories BNK Canada, Inc. for clinical studies related to the MSN-2 medical device. The MSN-2 is a home kit designed for the detection of sexually transmitted infections (STIs) from a self-obtained gynecological specimen. MSN-2 has been confirmed through studies to detect…

FridayApr 20, 2018 3:34 pm

QualityStocksNewsBreaks – Earth Science Tech, Inc. (ETST) Projects a Breakout Year in 2018

Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, is following through on its objective to reach new heights in the alternative medicine market. An article discussing the company reads: “Earth Science Tech, Inc. (OTC: ETST), by naming Gagan Hunter as its new COO, has completed a transition, positioning the company to reach ‘new heights’ with a new team in place and a revamped marketing strategy for its industrial hemp-sourced line as a cannabinoid complex, as detailed by Nickolas Tabraue, company director and president, in a recent news release (http://ibn.fm/lIhvd). Tabraue,…

WednesdayApr 18, 2018 12:28 pm

Earth Science Tech, Inc. (ETST) Has Team in Place to Become Licensed Distributor of Controlled Substances in Canada

Jad Nammour joins the company as new Chief of Pharmacy, bringing over 20 years of experience to ETST Positioned for sales growth with a strong, completed team of industry professionals Accelerating the development and commercialization of new products in Canada and overseas Earth Science Tech, Inc. (OTC: ETST), a Florida-based biotech company focused on cannabis and cannabinoid research and development, nutraceuticals and pharmaceuticals, as well as on R&D for certain medical devices, recently announced Jad Nammour as its new Chief of Pharmacy (http://ibn.fm/dnv0x). Nammour is trained to develop master formulae, the templates for mass production of non-sterile medicinal products. Having a…

WednesdayApr 11, 2018 10:10 am

QualityStocksNewsBreaks – Earth Science Tech, Inc. (ETST) Names New Chief of Pharmacy

Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, this morning announced that Jad Nammour has joined the company as its new Chief of Pharmacy. Nammour has over 20 years of experience as a pharmacist, as well as a specialized certification in the preparation of magisterial formulas. Nammour’s duties include ensuring that controlled substances and drugs are managed and handled correctly in accordance with regulations. He will also oversee all of the company’s storage and warehousing of any controlled substances. “The addition of Jad Nammour to our team means that the…

TuesdayApr 10, 2018 1:14 pm

Earth Science Tech, Inc. (ETST) on Course to Complete White Paper Studies in 2019

ETST will investigate combination drugs that combine a mineral element with full spectrum cannabinoid industrial hemp oil; it anticipates completion of white paper studies in early 2019, with clinical trials to follow Goal is to produce both an OTC nutraceutical product and a cannabinoid companion generic drug to fight the epidemic of opioid dependency Foundations Wellness Center reports that two million Americans are now addicted to opioids Earth Science Tech, Inc. (OTC: ETST) has set 2019 as the crucial year when the company anticipates completion of white paper studies and the start of human clinical trials to investigate the synergies…

MondayApr 09, 2018 2:51 pm

QualityStocksNewsBreaks – Earth Science Tech, Inc. (ETST) Reports Record-breaking Sales Revenue in February

Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, recently announced that February marked the company’s highest-ever sales revenue month. The company reported a 90% revenue increase compared to February 2017 (http://ibn.fm/Vhnbh). An article discussing the company reads: “In a news release, Nickolas Tabraue, company president, director and COO, noted February to be a pivotal month, giving praise to newly appointed CSO Jill Buzan while appointing Gabriel Aviles as the company’s chief learning officer. “Jill Buzan has brought so much to our company, and with her experience and knowledge Earth Science…

WednesdayApr 04, 2018 3:14 pm

QualityStocksNewsBreaks – Earth Science Tech, Inc. (ETST) Subsidiary Demonstrates Innovation in the Pharmaceutical Industry

Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, recently said that its subsidiary, Canna Inno Laboratories Inc., received a grant from the Government of Québec for innovation in the pharmaceutical industry. An article discussing the company reads: “Earth Science Tech formed Canna Inno Laboratories, Inc. in 2017. Strategically headquartered in Montreal, Quebec, it allows Earth Science Tech access to Canadian government and private grants offered to companies for innovation in the pharmaceutical industry. The awarded grant will support the pre-launch process of Earth Science’s three CBD-based products. These nutraceutical products…

Site Search

Company Search

Tag: Earth Science Tech Inc. ETST